Literature DB >> 24030502

Blood pressure and cognition: factors that may account for their inconsistent association.

Melinda C Power1, Eric J Tchetgen Tchetgen, David Sparrow, Joel Schwartz, Marc G Weisskopf.   

Abstract

BACKGROUND: Studies of hypertension and cognition variously report adverse, null, and protective associations. We evaluated evidence supporting three potential explanations for this variation: an effect of hypertension duration, an effect of age at hypertension initiation, and selection bias due to dependent censoring.
METHODS: The Normative Aging Study is a prospective cohort study of men in the greater Boston area. Participants completed study visits, including hypertension assessment, every 3-5 years starting in 1961. Seven hundred fifty-eight of 1,284 men eligible at baseline completed cognitive assessment between 1992 and 2005; we used the mean age-adjusted cognitive test Z score from their first assessment to quantify cognition. We estimated how becoming hypertensive and increasing age at onset and duration since hypertension initiation affect cognition. We used inverse probability of censoring weights to reduce and quantify selection bias.
RESULTS: A history of hypertension diagnosis predicted lower cognition. Increasing duration since hypertension initiation predicted lower mean cognitive Z score (-0.02 standard units per year increase [95% confidence interval= -0.04 to -0.001]), independent of age at onset. Comparing participants with and without hypertension, we observed noteworthy differences in mean cognitive score only for those with a long duration since hypertension initiation, regardless of age at onset. Age at onset was not associated with cognition independent of duration. Analyses designed to quantify selection bias suggested upward bias.
CONCLUSIONS: Previous findings of null or protective associations between hypertension and cognition likely reflect the study of persons with short duration since hypertension initiation. Selection bias may also contribute to cross-study heterogeneity.

Entities:  

Mesh:

Year:  2013        PMID: 24030502      PMCID: PMC3818218          DOI: 10.1097/EDE.0b013e3182a7121c

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  33 in total

Review 1.  Update on hypertension and Alzheimer's disease.

Authors:  Ingmar Skoog; Deborah Gustafson
Journal:  Neurol Res       Date:  2006-09       Impact factor: 2.448

2.  Midlife cardiovascular risk factors and risk of dementia in late life.

Authors:  R A Whitmer; S Sidney; J Selby; S Claiborne Johnston; K Yaffe
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

3.  Measuring cognitive function with age: the influence of selection by health and survival.

Authors:  Sjoerd M Euser; Miranda T Schram; Albert Hofman; Rudi G J Westendorp; Monique M B Breteler
Journal:  Epidemiology       Date:  2008-05       Impact factor: 4.822

Review 4.  Blood pressure reduction for vascular risk: is there a price to be paid?

Authors:  Jonathan Birns; Hugh Markus; Lalit Kalra
Journal:  Stroke       Date:  2005-04-28       Impact factor: 7.914

5.  Reducing the risk of dementia: efficacy of long-term treatment of hypertension.

Authors:  Rita Peila; Lon R White; Kamal Masaki; Helen Petrovitch; Lenore J Launer
Journal:  Stroke       Date:  2006-04-06       Impact factor: 7.914

6.  Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

Authors:  Kwok Leung Ong; Bernard M Y Cheung; Yu Bun Man; Chu Pak Lau; Karen S L Lam
Journal:  Hypertension       Date:  2006-12-11       Impact factor: 10.190

Review 7.  The age-dependent relation of blood pressure to cognitive function and dementia.

Authors:  Chengxuan Qiu; Bengt Winblad; Laura Fratiglioni
Journal:  Lancet Neurol       Date:  2005-08       Impact factor: 44.182

8.  Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study.

Authors:  M F Elias; P A Wolf; R B D'Agostino; J Cobb; L R White
Journal:  Am J Epidemiol       Date:  1993-09-15       Impact factor: 4.897

9.  Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study.

Authors:  Ge Li; Isaac C Rhew; Jane B Shofer; Walter A Kukull; John C S Breitner; Elaine Peskind; James D Bowen; Wayne McCormick; Linda Teri; Paul K Crane; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2007-08       Impact factor: 5.562

10.  Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study.

Authors:  M E Farmer; S J Kittner; R D Abbott; M M Wolz; P A Wolf; L R White
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

View more
  27 in total

1.  Diabetes in midlife and cognitive change over 20 years: a cohort study.

Authors:  Andreea M Rawlings; A Richey Sharrett; Andrea L C Schneider; Josef Coresh; Marilyn Albert; David Couper; Michael Griswold; Rebecca F Gottesman; Lynne E Wagenknecht; B Gwen Windham; Elizabeth Selvin
Journal:  Ann Intern Med       Date:  2014-12-02       Impact factor: 25.391

2.  Smoking and white matter hyperintensity progression: the ARIC-MRI Study.

Authors:  Melinda C Power; Jennifer A Deal; A Richey Sharrett; Clifford R Jack; David Knopman; Thomas H Mosley; Rebecca F Gottesman
Journal:  Neurology       Date:  2015-01-28       Impact factor: 9.910

3.  Association of midlife lipids with 20-year cognitive change: A cohort study.

Authors:  Melinda C Power; Andreea Rawlings; A Richey Sharrett; Karen Bandeen-Roche; Josef Coresh; Christie M Ballantyne; Yashashwi Pokharel; Erin D Michos; Alan Penman; Alvaro Alonso; David Knopman; Thomas H Mosley; Rebecca F Gottesman
Journal:  Alzheimers Dement       Date:  2017-09-12       Impact factor: 21.566

4.  Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia.

Authors:  Keenan A Walker; A Richey Sharrett; Aozhou Wu; Andrea L C Schneider; Marilyn Albert; Pamela L Lutsey; Karen Bandeen-Roche; Josef Coresh; Alden L Gross; B Gwen Windham; David S Knopman; Melinda C Power; Andreea M Rawlings; Thomas H Mosley; Rebecca F Gottesman
Journal:  JAMA       Date:  2019-08-13       Impact factor: 56.272

Review 5.  Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review.

Authors:  Keenan A Walker; Melinda C Power; Rebecca F Gottesman
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

Review 6.  Statins, cognition, and dementia—systematic review and methodological commentary.

Authors:  Melinda C Power; Jennifer Weuve; A Richey Sharrett; Deborah Blacker; Rebecca F Gottesman
Journal:  Nat Rev Neurol       Date:  2015-03-24       Impact factor: 42.937

7.  Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study.

Authors:  Rebecca F Gottesman; Andrea L C Schneider; Marilyn Albert; Alvaro Alonso; Karen Bandeen-Roche; Laura Coker; Josef Coresh; David Knopman; Melinda C Power; Andreea Rawlings; A Richey Sharrett; Lisa M Wruck; Thomas H Mosley
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

8.  The role of functional status on the relationship between blood pressure and cognitive decline: the Cardiovascular Health Study.

Authors:  Lindsay M Miller; Carmen A Peralta; Annette L Fitzpatrick; Chenkai Wu; Bruce M Psaty; Anne B Newman; Michelle C Odden
Journal:  J Hypertens       Date:  2019-09       Impact factor: 4.844

9.  Life-course blood pressure in relation to brain volumes.

Authors:  Melinda C Power; Andrea L C Schneider; Lisa Wruck; Michael Griswold; Laura H Coker; Alvaro Alonso; Clifford R Jack; David Knopman; Thomas H Mosley; Rebecca F Gottesman
Journal:  Alzheimers Dement       Date:  2016-04-29       Impact factor: 21.566

10.  Multiple imputation of cognitive performance as a repeatedly measured outcome.

Authors:  Andreea Monica Rawlings; Yingying Sang; Albert Richey Sharrett; Josef Coresh; Michael Griswold; Anna Maria Kucharska-Newton; Priya Palta; Lisa Miller Wruck; Alden Lawrence Gross; Jennifer Anne Deal; Melinda Carolyn Power; Karen Jean Bandeen-Roche
Journal:  Eur J Epidemiol       Date:  2016-09-12       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.